MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene Therapy – Markets Insider
|
MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene Therapy
Markets Insider SAN FRANCISCO, Jan. 25, 2018 /PRNewswire/ — MultiVir Inc. presented updated data at the annual ASCO-SITC Clinical Immuno-Oncology Symposium demonstrating the ability of its immune gene therapies to reverse resistance to immune checkpoint inhibitor … |
